Protalix BioTherapeutics, Inc. (PLX)

NYSEAMERICAN: PLX · Real-Time Price · USD

2.370

+0.050 (2.16%)

At close: Aug 4, 2026, 4:00 PM EDT

2.370

0.00 (0.00%)

After-hours: Aug 4, 2026, 5:13 PM EDT

Protalix BioTherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	191	145	143	130	74	38
Market Cap Growth	65.47%	1.52%	9.81%	76.21%	94.49%	-69.98%
Enterprise Value	148.35	122.81	113.29	111.58	84.99	32.37
Last Close Price	2.37	1.80	1.88	1.78	1.37	0.83

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.27	-	47.00	19.78	-	-
Forward PE	-	10.29	3.94	13.17	60.89	111.67
PS Ratio	2.50	2.74	2.67	1.98	1.55	0.99
PB Ratio	2.84	3.00	3.30	3.87	-6.93	-6.28
P/TBV Ratio	2.86	2.93	3.53	4.37	-	-
P/FCF Ratio	14.69	-	19.29	-	-	-
P/OCF Ratio	12.65	-	16.44	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.94	2.33	2.12	1.70	1.78	0.84
EV/EBITDA Ratio	6.96	-	21.70	9.58	-	-
EV/EBIT Ratio	7.50	-	28.92	10.67	-	-
EV/FCF Ratio	11.41	-	15.33	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.10	0.14	0.09	0.14	-3.04	-5.35
Debt / EBITDA Ratio	0.40	-	1.06	2.26	-	-
Debt / FCF Ratio	0.65	-	0.75	-	-	-
Net Debt / Equity Ratio	-0.63	-0.45	-0.68	-0.55	-1.06	0.91
Net Debt / EBITDA Ratio	-2.00	5.44	-5.61	-1.57	-0.95	0.28
Net Debt / FCF Ratio	-3.28	1.61	-3.96	7.41	-0.44	0.47
Asset Turnover	0.83	0.68	0.68	0.93	0.74	0.54
Inventory Turnover	0.82	1.15	1.21	1.28	1.13	1.05
Quick Ratio	1.97	1.47	1.47	1.09	0.83	1.28
Current Ratio	3.15	2.51	2.34	1.54	1.38	1.86
Return on Equity (ROE)	30.01%	-10.09%	14.00%	76.93%	166.31%	166.80%
Return on Assets (ROA)	19.27%	-5.81%	6.42%	15.36%	-19.37%	-28.90%
Return on Invested Capital (ROIC)	69.92%	-22.51%	34.73%	55.73%	-39.27%	-186.45%
Return on Capital Employed (ROCE)	30.27%	-10.62%	9.04%	33.60%	-40.77%	-186.45%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	8.03%	-	2.13%	5.06%	-	-
FCF Yield	6.81%	-	5.18%	-	-	-
Buyback Yield / Dilution	2.19%	3.10%	1.66%	-70.04%	-9.81%	-51.43%
Total Shareholder Return	2.19%	3.10%	1.66%	-70.04%	-9.81%	-51.43%

SEC Filings: 10-K · 10-Q